Shield Therapeutics plc STX
LON: STX | ISIN: GB00BYV81293 29/04/2025
2,350 GBX (0,00%)
(0,00%)
29/04/2025
Profiel Shield Therapeutics plc
CEO: Carl Andrew Sterritt